CD44-Serglycin interaction maintains tumoral cell stemness through CD44 upregulation (as part of a positive feedback loop) mediated by MAPK/β-catenin pathway activation in nasopharyngeal carcinoma cells (55). The gene discussed is CD44; the disease is nasopharyngeal carcinoma.